An unlimited future of saving lives and alleviating suffering
Developing new drugs is only the beginning. Many existing drugs are highly effective, but cannot be used because they are toxic to a small subset of patients. By testing these drugs in organoids grown with a variety of genomic signatures, we can determine which groups of patients can safely take these drugs and at what doses. As we enter a new era of personalized medicine, we will ultimately be able use an individual’s own cells, both healthy and diseased, to determine which drugs, at what doses and in which combinations, are best tailored to treat a particular person’s condition. The human organ-like constructs can also be used to model disease, with the potential to lead to new discoveries to prevent and reverse disease progression.